Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PRA
PRA logo

PRA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
24.990
Open
24.990
VWAP
--
Vol
--
Mkt Cap
--
Low
24.990
Amount
--
EV/EBITDA(TTM)
15.20
Total Shares
--
EV
1.70B
EV/OCF(TTM)
--
P/S(TTM)
1.20
ProAssurance Corporation is a holding company for property and casualty insurance companies. The Company operates through three segments, which include Specialty Property and Casualty, Workers Compensation Insurance and Segregated Portfolio Cell Reinsurance. Its Specialty Property and Casualty segment focuses on medical professional liability insurance and medical technology liability insurance. Its Workers Compensation Insurance segment offers workers compensation products in 19 core states in the East, South and Midwest regions of the continental United States. Its Segregated Portfolio Cell Reinsurance segment focuses on Segregated portfolio cell (SPCs) at Inova Re and Eastern Re, its Cayman Islands SPC operations. The Company’s insurance subsidiaries provide medical professional liability insurance, liability insurance for medical technology and life sciences risks and workers compensation insurance.
Show More

Events Timeline

(ET)
2026-06-26
09:30:00
The Doctors Company Acquires ProAssurance for $1.3 Billion
select
2026-06-03 (ET)
2026-06-03
11:30:00
ProAssurance Enters Merger Agreement with The Doctors Company
select
2026-05-05 (ET)
2026-05-05
17:00:00
ProAssurance Reports Q1 Revenue of $262.63M
select
2026-02-23 (ET)
2026-02-23
16:30:00
ProAssurance Q4 Revenue $201.52M, Below Consensus
select
2025-11-04 (ET)
2025-11-04
16:21:40
ProAssurance announces Q3 adjusted earnings per share of 15 cents, falling short of the 26-cent consensus.
select
2025-08-05 (ET)
2025-08-05
16:17:08
ProAssurance reports Q2 EPS 52c, consensus 21c
select
2025-06-24 (ET)
2025-06-24
16:15:58
ProAssurance stockholders approve proposed acquisition by The Doctors Company
select

News

PRnewswire
8.5
06-26PRnewswire
The Doctors Company Completes Acquisition of ProAssurance
  • Acquisition Finalized: The Doctors Company has completed the acquisition of ProAssurance for $25 per share in cash, totaling approximately $1.3 billion, which will enable the combined entity to protect over 200,000 healthcare professionals, significantly enhancing market position.
  • Strategic Integration: ProAssurance will operate as a wholly owned subsidiary of The Doctors Company, with both organizations committed to delivering exceptional service and long-term stability in a complex healthcare landscape, thereby increasing client trust.
  • Market Impact: This merger positions The Doctors Company as the largest provider of medical liability and specialty insurance in the U.S., with total assets reaching $12 billion and direct written premiums exceeding $2.5 billion, further solidifying its leadership in the healthcare insurance market.
  • Shareholder Approval: ProAssurance shareholders approved the transaction in June 2025, marking a deep collaboration in the medical liability insurance sector, which is expected to drive future business growth and innovation.
Newsfilter
8.5
06-24Newsfilter
NETSTREIT to Replace ProAssurance in S&P SmallCap 600 Index
  • Index Change: NETSTREIT Corp. will replace ProAssurance Corp. in the S&P SmallCap 600 Index effective June 29, 2026, which is expected to enhance NETSTREIT's market visibility and liquidity.
  • Acquisition Context: ProAssurance is being acquired by The Doctors Company in a cash deal expected to close soon, which will impact ProAssurance's market positioning and future growth prospects.
  • Market Impact: The inclusion of NETSTREIT may attract more investor attention, particularly in the real estate sector, and is anticipated to boost its stock price while strengthening its competitive position in the small-cap market.
  • Importance of S&P Index: As the largest index provider globally, S&P Dow Jones Indices' changes significantly influence investor decisions and market trends, and NETSTREIT's addition will further solidify its position in investment products.
seekingalpha
8.5
06-24seekingalpha
NETSTREIT to Replace ProAssurance in S&P SmallCap 600 Index
  • Index Component Change: S&P Dow Jones Indices announced that NETSTREIT will replace ProAssurance in the S&P SmallCap 600 Index on June 29, indicating a growing interest in small-cap REITs that may attract more investor attention.
  • Acquisition Impact: ProAssurance is set to be acquired by The Doctors Company in an all-cash deal expected to close soon, which could affect ProAssurance's market performance and investor confidence.
  • NETSTREIT Performance: NETSTREIT demonstrated strong performance in Q1, showcasing its growth potential as a retail REIT, further solidifying its position in the small-cap market.
  • Market Dynamics: Small-cap REIT stocks showed divergence in May, with NETSTREIT topping the most-shorted list, reflecting mixed market sentiment regarding its future performance while indicating a rising interest in small-cap REITs among investors.
PRnewswire
8.5
06-24PRnewswire
NETSTREIT to Replace ProAssurance in S&P SmallCap 600 Index
  • Index Change: NETSTREIT Corp. will replace ProAssurance Corp. in the S&P SmallCap 600 Index effective June 29, 2026, which is expected to enhance NETSTREIT's market visibility and attract investor interest.
  • Acquisition Update: ProAssurance is being acquired by Doctors Company in a cash deal expected to close soon, which will impact ProAssurance's market position and future growth prospects.
  • Market Impact: The inclusion of NETSTREIT may draw more investor attention to its stock, potentially driving up its share price, while also affecting the overall performance of the S&P SmallCap 600 Index.
  • Industry Context: S&P Dow Jones Indices is one of the largest index providers globally, and NETSTREIT's inclusion further solidifies its representation in the real estate sector, reflecting ongoing market confidence in this industry.
seekingalpha
8.5
06-03seekingalpha
ProAssurance Receives Approval for Sale to Doctors Company
  • Stock Price Increase: ProAssurance (PRO) shares rose by 2%, reflecting market optimism regarding its transaction with Doctors Company, indicating increased investor confidence in the company's future prospects.
  • Regulatory Approval Progress: The company has received approval from Pennsylvania's insurance regulator, marking a significant step forward for the transaction, although it still awaits approval from California regulators, highlighting the complexity of the deal's completion.
  • Transaction Value: The total value of the deal is $1.3 billion, equating to $25 per share in cash, indicating Doctors Company's commitment to ProAssurance and its intent to expand in the healthcare insurance market.
  • Completion Timeline: ProAssurance reiterated its expectation to close the transaction by June 30, demonstrating confidence in the process while providing shareholders with a clear timeline for the deal's finalization.
seekingalpha
9.5
05-05seekingalpha
ProAssurance Q1 Earnings Report Analysis
  • Earnings Miss: ProAssurance reported a Q1 GAAP EPS of $0.16, missing expectations by $0.09, indicating pressure on profitability that could undermine investor confidence.
  • Revenue Decline: The company generated revenue of $262.63 million, a 3.5% year-over-year decrease, although it beat market expectations by $1.95 million, the ongoing revenue decline poses challenges for future growth.
  • Market Reaction Analysis: Given the earnings miss, the market may adopt a cautious stance towards ProAssurance's future performance, prompting investors to monitor the company's strategic adjustments and market responses closely.
  • Financial Health Outlook: Despite a slight revenue beat, the persistent decline in profitability may lead to increased financing costs in capital markets, potentially impacting the company's long-term growth strategy.

Valuation Metrics

The current forward P/E ratio for Proassurance Corp (PRA.N) is 16.86, compared to its 5-year average forward P/E of 210.95. For a more detailed relative valuation and DCF analysis to assess Proassurance Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
210.95
Current PE
16.86
Overvalued PE
1018.04
Undervalued PE
-596.14

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
1.57
Current EV/EBITDA
21.55
Overvalued EV/EBITDA
6.56
Undervalued EV/EBITDA
-3.43

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.94
Current PS
1.27
Overvalued PS
1.17
Undervalued PS
0.71

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Top stock for one week gain
Intellectia · 645 candidates
Region: USRsi Category: moderateMoving Average Relationship: PriceAboveMA5, PriceAboveMA20Week Price Change Pct: >= $0.00One Week Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
IMPP logo
IMPP
Imperial Petroleum Inc
226.00M
TALK logo
TALK
Talkspace Inc
869.39M
PRA logo
PRA
Proassurance Corp
1.28B
RGP logo
RGP
Resources Connection Inc
140.41M
NOV logo
NOV
Nov Inc
7.45B
THR logo
THR
Thermon Group Holdings Inc
1.95B
stocks with wolfe wave buy signals
Intellectia · 43 candidates
Relative Vol: >= 0.800Rsi 14: 40 - 70Moving Average Relationship: PriceAboveMA20Candlestick Pattern: WhiteCandlestickSupport Resistance Relationship: PriceAroundSupport
Ticker
Name
Market Cap$
top bottom
SCHW logo
SCHW
Charles Schwab Corp
180.87B
UBS logo
UBS
UBS Group AG
148.23B
BCS logo
BCS
Barclays PLC
89.27B
ING logo
ING
ING Groep NV
83.26B
NSC logo
NSC
Norfolk Southern Corp
64.87B
MFC logo
MFC
Manulife Financial Corp
62.58B

Whales Holding PRA

W
Westchester Capital Management, LLC
Holding
PRA
+2.05%
3M Return
M
Magnetar Capital Partners, LP
Holding
PRA
-0.19%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Proassurance Corp (PRA) stock price today?

The current price of PRA is 24.99 USD — it has increased 0

What is Proassurance Corp (PRA)'s business?

ProAssurance Corporation is a holding company for property and casualty insurance companies. The Company operates through three segments, which include Specialty Property and Casualty, Workers Compensation Insurance and Segregated Portfolio Cell Reinsurance. Its Specialty Property and Casualty segment focuses on medical professional liability insurance and medical technology liability insurance. Its Workers Compensation Insurance segment offers workers compensation products in 19 core states in the East, South and Midwest regions of the continental United States. Its Segregated Portfolio Cell Reinsurance segment focuses on Segregated portfolio cell (SPCs) at Inova Re and Eastern Re, its Cayman Islands SPC operations. The Company’s insurance subsidiaries provide medical professional liability insurance, liability insurance for medical technology and life sciences risks and workers compensation insurance.

What is the price predicton of PRA Stock?

Wall Street analysts forecast PRA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Proassurance Corp (PRA)'s revenue for the last quarter?

Proassurance Corp revenue for the last quarter amounts to 261.24M USD, decreased -1.73

What is Proassurance Corp (PRA)'s earnings per share (EPS) for the last quarter?

Proassurance Corp. EPS for the last quarter amounts to 0.16 USD, decreased -245.45

How many employees does Proassurance Corp (PRA). have?

Proassurance Corp (PRA) has 972 emplpoyees as of July 07 2026.

What is Proassurance Corp (PRA) market cap?

Today PRA has the market capitalization of 0.00 USD.